Cargando…
Remdesivir in a pregnant patient with COVID-19 pneumonia
Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non...
Autores principales: | Dande, Ranadheer, Qureshi, Anum, Persaud, Kia, Puri, Chahat, Zulfiqar, Sajida, Awasthi, Shankar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850401/ https://www.ncbi.nlm.nih.gov/pubmed/33552429 http://dx.doi.org/10.1080/20009666.2020.1857510 |
Ejemplares similares
-
Atypical Pyoderma gangrenosum: a case of delayed recognition
por: Qureshi, Anum, et al.
Publicado: (2021) -
The many manifestations of a single disease: neuroborreliosis
por: Zulfiqar, Sajida, et al.
Publicado: (2021) -
Baffling Case of a Patient With History of Lupus in a COVID-19 Pandemic
por: Qureshi, Anum, et al.
Publicado: (2022) -
Treatment With Remdesivir in Two Pregnant Patients With COVID-19 Pneumonia
por: Singh, Vinita, et al.
Publicado: (2021) -
Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report
por: Saroyo, Yudianto Budi, et al.
Publicado: (2021)